Research Paper Volume 13, Issue 5 pp 6982—6998
Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment
Figure 5. Immunohistochemistry and Western blot analysis of tumor xenografts. (A) Ki67, TUNEL and AR of different group xenografts were stained and evaluated at 100× magnifications. (B) AR and PSA of a representative xenograft in each group were analyzed by Western blot.